Nyse ogn

About Organon Organon (NYSE: OGN) is a global healthcare company formed through a spin-off from Merck & Co., Inc., Rahway, NJ, USA (NYSE: MRK) to focus on ....

The current 4.56 price-to-earnings ratio is 28% less than the historical average. Analyzing the last three years, OGN's PE ratio reached its highest point in the Mar 2023 quarter at 8.03, with a price of $23.52 and an EPS of $2.93. The Dec 2023 quarter saw the lowest point at 3.6, with a price of $14.42 and an EPS of $4.01. Average. 6.36. Median.Organon & Co.'s most recent quarterly dividend payment of $0.28 per share was made to shareholders on Thursday, March 14, 2024. When was Organon & Co.'s most recent ex-dividend date? Organon & Co.'s most recent ex-dividend date was Friday, February 23, 2024. What is Organon & Co.'s dividend payout ratio?

Did you know?

Written by MarketBeat. March 3, 2024. Alps Advisors Inc. raised its stake in shares of Organon & Co. ( NYSE:OGN - Free Report) by 12.0% during the 3rd quarter, according to the company in its most recent filing with the SEC. The firm owned 1,529,586 shares of the company's stock after purchasing an additional …Complete Organon & Co. stock information by Barron's. View real-time OGN stock price and news, along with industry-best analysis.JERSEY CITY, N.J.--(BUSINESS WIRE)-- Organon (NYSE: OGN) today affirmed prior revenue and Adjusted EBITDA guidance, indicated that free cash flow before one-time spin-related costs is expected to be above the high end of the previous guidance range, and provided high-level financial objectives for 2024. …

AQR Capital Management LLC grew its position in shares of Organon & Co. (NYSE:OGN - Free Report) by 10.8% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC).The institutional investor owned 1,781,449 shares of the company's stock after purchasing an additional 173,778 shares during …Complete Organon & Co. stock information by Barron's. View real-time OGN stock price and news, along with industry-best analysis.Organon & Co. is a science based global pharmaceutical company that develops and delivers innovative health solutions through a portfolio of prescription therapies within women’s health, biosimilars and established brands. The company is headquartered in Jersey City, New Jersey and currently employs 9,300 full-time …This page (NYSE:OGN) was last updated on 3/26/2024 by MarketBeat.com Staff. From Our Partners. top AI stock (it's not MSFT, GOOGL, AMZN or AAPL) Traders ...Douglas Lane & Associates LLC trimmed its stake in shares of Organon & Co. (NYSE:OGN - Free Report) by 43.3% in the fourth quarter, according to the company in its most recent filing with the SEC. The firm owned 360,775 shares of the company's stock after selling 276,056 shares during the quarter.

GUANGZHOU, China, Aug. 2, 2022 /PRNewswire/ -- Yatsen Holding Limited ('Yatsen' or the 'Company') (NYSE: YSG), a leading Chinese beauty company, t... GUANGZHOU, China, Aug. 2, 2022... You can pay your NYSEG bill with a credit or debit card. Make A Payment. There is no cost for this service. Prefer other no-cost options? View our full range of ways to pay your bill. You will be able to accept or decline the transaction prior to submitting the payment. Please allow up to three days for processing. Organon & Co. Annual stock financials by MarketWatch. View the latest OGN financial statements, income statements and financial ratios. ….

Reader Q&A - also see RECOMMENDED ARTICLES & FAQs. Nyse ogn. Possible cause: Not clear nyse ogn.

According to the issued ratings of 4 analysts in the last year, the consensus rating for Organon & Co. stock is Moderate Buy based on the current 2 hold ratings and 2 buy ratings for OGN. The average twelve-month price prediction for Organon & Co. is $21.80 with a high price target of $28.00 and a low price target of $18.00.We are days away from pharmaceutical house Organon & Co. (NYSE:OGN) going ex-dividend. We own the stock since May 2021 plowing the ~5% yield, or $0.28 per share, back into our reinvestment plan ...

With a dividend yield of about 8%, New Jersey-based pharmaceutical company Organon & Co (NYSE:OGN) ranks 9th in our list of the best low-priced dividend stocks.NYSE Connect - Preferred - ICE WebStart To download ICE WebStart, please click this link and follow the instructions. If you are unable to launch NYSE Connect with ICE WebStart, please review our system requirements .

classified ads for free Algert Global LLC reduced its stake in shares of Organon & Co. (NYSE:OGN - Free Report) by 23.2% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 111,891 shares of the company's stock after selling 33,861 shares d brenda walsh ministriesget your marriage on Q4 2023. Organon & Co. beats earnings expectations. Reported EPS is $0.88, expectations were $0.8. Organon & Co. - Part 2. bank of the sierra online banking The latest price target for . Organon (NYSE: OGN) was reported by Goldman Sachs on Tuesday, February 20, 2024.The analyst firm set a price target for 18.00 expecting OGN to rise to within 12 ... cast trynorthern western mutualpre k three This page (NYSE:OGN) was last updated on 3/26/2024 by MarketBeat.com Staff. From Our Partners. top AI stock (it's not MSFT, GOOGL, AMZN or AAPL) Traders ...Organon & Co. Trading Up 0.7 %. Shares of OGN opened at $17.93 on Wednesday. The stock has a market capitalization of $4.58 billion, a P/E ratio of 4.47, a price-to-earnings-growth ratio of 0.86 ... infinite pokedoku At the New York Stock Exchange, we protect market integrity and drive innovation that connects investors to opportunity. NYSE markets offer multiple trading models to provide a superior trading environment NYSE, NYSE American Equities, NYSE Arca Equities, NYSE Chicago, and NYSE National all operate using NYSE Pillar, our integrated trading technology platform that is … comerica comerica bankmy utilityoasis login employee Organon (NYSE: OGN) is a global healthcare company formed through a spinoff from Merck, known as MSD outside of the United States and Canada, to focus on improving the health of women throughout their lives. Here for her health, the company has a portfolio of more than 60 medicines and products across a range of therapeutic areas. …